Literature DB >> 27277266

Evaluation of transcatheter arterial embolization therapy on hepatocellular carcinomas using contrast-enhanced harmonic power Doppler sonography: comparison with CT, power Doppler sonography, and dynamic MRI.

Toshihide Shima1, Masayuki Mizuno2, Hideaki Otsuji3, Chiemi Mizuno2, Hirozumi Obata2, Hyohun Park2, Shinobu Nakajo2, Takeshi Okanoue4.   

Abstract

PURPOSE: The aim of this study was to assess and compare the sensitivity of power Doppler sonography, contrast-enhanced sonography, plain computed tomography (CT), and dynamic magnetic resonance imaging (MRI) for detecting hepatocellular carcinoma (HCC) nodules incompletely treated with transcatheter arterial embolization (TAE).
METHODS: A total of 63 unresectable HCC nodules were examined in this study. The HCCs were treated with TAE. All patients underwent plain CT, power Doppler sonography, contrast-enhanced harmonic power Doppler sonography, and dynamic MRI 1 week after TAE. The sensitivity of each modality to incompletely treated HCC nodules was compared. Detection of the residual viable HCC on angiography or tumor biopsy was regarded as the gold standard for the diagnosis of incomplete treatment.
RESULTS: Twenty-four nodules (38%) were diagnosed as incompletely treated. The sensitivities of plain CT, power Doppler sonography, contrast-enhanced harmonic power Doppler sonography, and dynamic MRI to these incompletely treated nodules were 42% (10/24), 46% (11/24), 88% (21/24), and 79% (19/24), respectively. Eighty percent (19 nodules) of the 24 incompletely treated nodules were located within a depth of less than 8 cm. The sensitivities of plain CT, power Doppler sonography, contrast-enhanced harmonic power Doppler sonography, and dynamic MRI to these superficial incompletely treated nodules were 37% (7/19), 53% (10/19), 100% (19/19), and 74% (14/19), respectively. In contrast, the sensitivities of each modality to deeply located nodules were 60% (3/5), 20% (1/5), 40% (2/5), and 100% (5/5), respectively.
CONCLUSION: Plain CT and power Doppler sonography had a low sensitivity to HCC nodules incompletely treated with TAE. Except for those that were deeply located, contrast-enhanced harmonic sonography showed the highest sensitivity in detecting incompletely treated HCC nodules.

Entities:  

Keywords:  contrast-enhanced harmonic power Doppler sonography; dynamic MRI; hepatocellular carcinoma; therapeutic effect; transcatheter arterial embolization

Year:  2005        PMID: 27277266     DOI: 10.1007/s10396-005-0045-z

Source DB:  PubMed          Journal:  J Med Ultrason (2001)        ISSN: 1346-4523            Impact factor:   1.314


  19 in total

1.  Evaluation of posttreatment response of hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: comparison with dynamic CT.

Authors:  H Ding; M Kudo; H Onda; Y Suetomi; Y Minami; H Chung; T Kawasaki; K Maekawa
Journal:  Radiology       Date:  2001-12       Impact factor: 11.105

2.  Transcatheter arterial chemoembolization of hepatocellular carcinoma: usefulness of coded phase-inversion harmonic sonography.

Authors:  Yasunori Minami; Masatoshi Kudo; Toshihiko Kawasaki; Masayuki Kitano; Hobyung Chung; Kiyoshi Maekawa; Hitoshi Shiozaki
Journal:  AJR Am J Roentgenol       Date:  2003-03       Impact factor: 3.959

3.  Small hepatocellular carcinoma in patients with chronic liver damage: prospective comparison of detection with dynamic MR imaging and helical CT of the whole liver.

Authors:  Y Yamashita; K Mitsuzaki; T Yi; I Ogata; T Nishiharu; J Urata; M Takahashi
Journal:  Radiology       Date:  1996-07       Impact factor: 11.105

4.  Clinical utility of doppler ultrasonography in evaluation of early therapeutic efficacy after transcatheter arterial embolization in patients with hepatocellular carcinoma.

Authors:  Toshio Hibi; Takashi Kumada; Kenji Takeshima; Masuhiro Ito; Takahiro Noda; Shigemasa Goto; Fumiyoshi Sugita; Toshi Sassa; Hideo Ichikawa; Satoshi Nakano
Journal:  J Med Ultrason (2001)       Date:  2002-06       Impact factor: 1.314

5.  Using contrast-enhanced sonography to assess the effectiveness of transcatheter arterial embolization for hepatocellular carcinoma.

Authors:  K Numata; K Tanaka; T Kiba; S Saito; T Isozaki; K Hara; M Morimoto; H Sekihara; H Yonezawa; T Kubota
Journal:  AJR Am J Roentgenol       Date:  2001-05       Impact factor: 3.959

6.  Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents.

Authors:  K Takayasu; Y Shima; Y Muramatsu; N Moriyama; T Yamada; M Makuuchi; H Hasegawa; S Hirohashi
Journal:  Radiology       Date:  1987-05       Impact factor: 11.105

7.  A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma.

Authors:  G Pelletier; A Roche; O Ink; M L Anciaux; S Derhy; P Rougier; C Lenoir; P Attali; J P Etienne
Journal:  J Hepatol       Date:  1990-09       Impact factor: 25.083

8.  Power Doppler sonography assessment of tumor recurrence after chemoembolization therapy for hepatocellular carcinoma.

Authors:  S Sumi; Y Yamashita; K Mitsuzaki; H Yamamoto; J Urata; T Nishiharu; M Takahashi
Journal:  AJR Am J Roentgenol       Date:  1999-01       Impact factor: 3.959

Review 9.  Small hepatocellular carcinoma: treatment with subsegmental transcatheter arterial embolization.

Authors:  O Matsui; M Kadoya; J Yoshikawa; T Gabata; K Arai; H Demachi; S Miyayama; T Takashima; M Unoura; K Kogayashi
Journal:  Radiology       Date:  1993-07       Impact factor: 11.105

10.  Color Doppler sonography of hepatocellular carcinoma before and after treatment by transcatheter arterial embolization.

Authors:  K Tanaka; S Inoue; K Numata; Y Takamura; S Takebayashi; Y Ohaki; K Misugi
Journal:  AJR Am J Roentgenol       Date:  1992-03       Impact factor: 3.959

View more
  2 in total

1.  Pseudoaneurysm in a chronic pancreatitis patient: report of a case, with emphasis on contrast-enhanced sonograms.

Authors:  Yoko Ohyama; Hideaki Ishida; Chioko Yoshida; Jyunko Konno; Takao Hoshino; Hiroyuki Watanabe; Yumi Kudoh; Kayoko Furukawa; Takako Watanabe
Journal:  J Med Ultrason (2001)       Date:  2009-11-07       Impact factor: 1.314

2.  Meta-analysis and systematic review of contrast-enhanced ultrasound in evaluating the treatment response after locoregional therapy of hepatocellular carcinoma.

Authors:  Yang Hai; Esika Savsani; Weelic Chong; John Eisenbrey; Andrej Lyshchik
Journal:  Abdom Radiol (NY)       Date:  2021-08-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.